Phenotype measures set:   Wiltshire4   Bcells_Ida

ID, description, units MPD:52441   Bcells_Ida   B cells, percent viability   [%]
idarubicin study
Measures • dose [µM]:    • control    • 0.046    • 0.137    • 1.235    • 11.1    • 100
Data set, strains Wiltshire4   inbred w/CC7   35 strains     sex: m     age: 10wks
Procedure immune cell quantification
Comparisoncontrol group vs. multiple treatment / dosage groups
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Wiltshire4 - B cells, percent viability





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
dose 5 1237104.2821 247420.8564 650.6598 < 0.0001
strain 34 75481.5132 2220.0445 5.8382 < 0.0001
dose:strain 170 128527.0208 756.0413 1.9882 < 0.0001
Residuals 608 231198.9683 380.2615

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelStrains
tested
SexAge
Wiltshire4 52441 immune cell quantification idarubicin B cells, percent viability   [%]   control   Bcells_Ida_ctrl inbred w/CC7 35 m 10wks
Wiltshire4 52442 immune cell quantification idarubicin B cells, percent viability   [%]   dose: 0.046 µM   Bcells_Ida_A inbred w/CC7 35 m 10wks
Wiltshire4 52443 immune cell quantification idarubicin B cells, percent viability   [%]   dose: 0.137 µM   Bcells_Ida_B inbred w/CC7 35 m 10wks
Wiltshire4 52444 immune cell quantification idarubicin B cells, percent viability   [%]   dose: 1.235 µM   Bcells_Ida_C inbred w/CC7 35 m 10wks
Wiltshire4 52445 immune cell quantification idarubicin B cells, percent viability   [%]   dose: 11.1 µM   Bcells_Ida_D inbred w/CC7 35 m 10wks
Wiltshire4 52446 immune cell quantification idarubicin B cells, percent viability   [%]   dose: 100 µM   Bcells_Ida_E inbred w/CC7 35 m 10wks